Any current/future new fundraising through debt or equity?

No specific mention of any current or immediate plans for new fundraising through debt or equity on the call. The company is focused on managing existing cash and investments prudently, with no plans for special dividends or similar payouts currently. Discussions about investments and growth primarily refer to internal growth via geographical expansion and digital strategy investments rather than capital raising. The board will decide on any special dividends or capital allocation at the end of the current quarter. No indication of debt or equity issuance in the near term; emphasis is on optim

Any current/future capex/capital investment/strategic investment?

The company is investing in growth with plans for geographical expansion starting next year. There is a focus on digital strategy investments, including aggressive digital marketing and upgrading contact center operations using technology, digital solutions, and skilled resources. The organization is on a cloud journey, having moved 92% of workload to Agile and progressing towards microservice-based architecture and an office-on-the-go model. UTI International is incurring one-time legal expenses to open an office in Paris and is also working on a US strategy which may incur one-time expenses

Future growth expectations in sales/revenue/volumes?

UTI MF expects growth driven by high-yielding assets, with a focus on improving equity scheme market share. The equity market share is targeted to improve quarter-on-quarter through pushing flagship products and deeper market penetration beyond top 50 cities. The ETF segment is growing, contributing to overall AUM expansion, though yielding lower fees, so revenues may moderate marginally. Positive inflows are expected in debt funds due to attractive yields amid policy rate peaking around 6.5%. Digital initiatives and geographic expansion are planned, potentially boosting future sales and AUM.

Future growth expectations in earnings/operating earnings/profits/EPS?

Focus on high-yielding assets expected to improve overall returns and earnings. Management committed to increasing market share in equity schemes, which could drive revenue growth. Anticipation of better equity yields to be shared in future calls (FY 23-24 outlook pending market stability). Debt segment outlook positive with expected inflows due to attractive yields (policy rate peaking around 6.5%). Expense management and digital/geographical expansion initiatives may support margin improvement. Variable pay and performance incentives are linked to scheme performance, aligning employee costs

UTI AMCQ3 FY23Capital Markets

UTI AMC Q3 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹842.2P/E: 18.0Market Cap: ₹10.8K CrSector: Capital Markets

Management growth scorecard

Revenue

Category 4

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 4

UTI MF expects growth driven by high-yielding assets, with a focus on improving equity scheme market share.
The equity market share is targeted to improve quarter-on-quarter through pushing flagship products and deeper market penetration beyond top 50 cities.
The ETF segment is growing, contributing to overall AUM expansion, though yielding lower fees, so revenues may moderate marginally.
Positive inflows are expected in debt funds due to attractive yields amid policy rate peaking around 6.5%.
Digital initiatives and geographic expansion are planned, potentially boosting future sales and AUM.
The board will review special dividend decisions, indicating prudent cash management aligned with growth plans.
Overall, revenues may see short-term volatility due to market conditions, but strategic focus on yield, product mix, and customer acquisition points to sustainable growth.

Margin guidance

Category 3

Focus on high-yielding assets expected to improve overall returns and earnings.
Management committed to increasing market share in equity schemes, which could drive revenue growth.
Anticipation of better equity yields to be shared in future calls (FY 23-24 outlook pending market stability).
Debt segment outlook positive with expected inflows due to attractive yields (policy rate peaking around 6.5%).
Expense management and digital/geographical expansion initiatives may support margin improvement.
Variable pay and performance incentives are linked to scheme performance, aligning employee costs with results.
No immediate plans for special dividend; retained earnings to be invested in growth strategies.
Revenue growth might face marginal dilution from increasing ETF share (lower fee yields) but overall AUM growth supports absolute revenue gains.
Market volatility currently limits forward-looking earnings guidance, but strategic focus on product and distribution depth is aimed at sustained growth.

See what UTI AMC management said on margin guidance — free account, 30 seconds.

Fundraise plans

No specific mention of any current or immediate plans for new fundraising through debt or equity on the call.
The company is focused on managing existing cash and investments prudently, with no plans for special dividends or similar payouts currently.
Discussions about investments and growth primarily refer to internal growth via geographical expansion and digital strategy investments rather than capital raising.
The board will decide on any special dividends or capital allocation at the end of the current quarter.
No indication of debt or equity issuance in the near term; emphasis is on optimizing existing resources and business growth.

Order book

The provided pages of the UTI Asset Management Company Limited Q3 FY23 Earnings Conference Call transcript do not contain specific information related to the current or expected order book or pending orders. The content primarily focuses on: - Asset under management (AUM) growth and market share details. - Investment strategy with focus on high-yielding assets. - Performance yields and distribution strategies. - Discussion on commission payouts, dividend policies, and digital initiatives. - Questions on equity market share, international business performance, and yield moderation. No mention or data regarding order books or pending orders is available in the extracted content. If you have a specific section or page in mind that covers that topic, please provide it for more precise information.

See what UTI AMC management said on order book — free account, 30 seconds.

Capex plans

Yes

The company is investing in growth with plans for geographical expansion starting next year.
There is a focus on digital strategy investments, including aggressive digital marketing and upgrading contact center operations using technology, digital solutions, and skilled resources.
The organization is on a cloud journey, having moved 92% of workload to Agile and progressing towards microservice-based architecture and an office-on-the-go model.
UTI International is incurring one-time legal expenses to open an office in Paris and is also working on a US strategy which may incur one-time expenses next year.
No special dividend or significant cash utilization planned at present; investments will support growth initiatives.
The board will decide on any special dividend after the current quarter.

Track UTI AMC — get its next earnings analysis in your feed

How does UTI AMC rank vs peers in Capital Markets?

Pro feature

ThisUTI AMC

Rev 4Mar 3

See where UTI AMC sits in Capital MarketsSee which companies these are, and every other name in the sector.Open rankings

How does UTI AMC rank in Capital Markets?

Compare UTI AMC against every Capital Markets company (Q3 FY23) on revenue, margins and earnings-call signals.

View Capital Markets leaderboard →

What UTI AMC's management said in earlier quarters

Earlier calls (8)

Others in Capital Markets this season

Systematix Corporate Services (Q2 FY27)
Q2 FY27 total revenue from operations (consolidated): ₹57.81 Cr, up 0.50% YoY vs. Key investor presentation takeaways from Systematix Corporate Services Ltd's Q
Indo Thai Securities (Q2 FY27)
Q2 FY27 revenue excluding fair value changes: ₹7.56 Cr, up 18.7% year-on-year (Page 13) . Key investor presentation takeaways from Indo Thai Securities Ltd's Q2
Gretex Corporate (Q2 FY27)
H1 FY27 saw an 11.4% year-on-year revenue growth, indicating positive momentum. Key concall takeaways from Gretex Corporate Services Ltd's Q2 FY27 earnings…
Nuvama Wealth (Q2 FY27)
Wealth and Private Wealth businesses have consistently compounded >20% growth over the last three years. Key concall takeaways from Nuvama Wealth Management…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →